Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

L. Bartmann; D. Schumacher; S. von Stillfried; M. Sternkopf; S. Alampour-Rajabi; M.A.M.J. van Zandvoort; F. Kiessling; Z.J. Wu

doi:10.3389/fphar.2020.617329

Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

L. Bartmann
, D. Schumacher
, S. von Stillfried
, M. Sternkopf
, S. Alampour-Rajabi
, M.A.M.J. van Zandvoort
, F. Kiessling^*
, Z.J. Wu^*

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum › Academic

Abstract

In the original article, there was an error. A statement on author contribution was incorrect. A correction has been made to the Author Contributions:.

Original language	English
Article number	617329
Number of pages	1
Journal	Frontiers in Pharmacology
Volume	11
DOIs	https://doi.org/10.3389/fphar.2020.617329
Publication status	Published - 26 Nov 2020

Keywords

cancer therapy
nanocarrier
rfvt
riboflavin
targeting molecules
theranostic
RFVT

Access to Document

10.3389/fphar.2020.617329Licence: CC BY

1 Article

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
Bartmann, L., Schumacher, D., von Stillfried, S., Sternkopf, M., Alampour-Rajabi, S., van Zandvoort, M. A. M. J., Kiessling, F. & Wu, Z., 6 Feb 2019, In: Frontiers in Pharmacology. 10, FEB, p. 1-12 12 p., 79.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

@article{96396b5423e846db80232a0dc3f6fb4e,

title = "Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics",

abstract = "In the original article, there was an error. A statement on author contribution was incorrect. A correction has been made to the Author Contributions:.",

keywords = "cancer therapy, nanocarrier, rfvt, riboflavin, targeting molecules, theranostic, RFVT",

author = "L. Bartmann and D. Schumacher and \{von Stillfried\}, S. and M. Sternkopf and S. Alampour-Rajabi and \{van Zandvoort\}, M.A.M.J. and F. Kiessling and Z.J. Wu",

year = "2020",

month = nov,

day = "26",

doi = "10.3389/fphar.2020.617329",

language = "English",

volume = "11",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

AU - Bartmann, L.

AU - Schumacher, D.

AU - von Stillfried, S.

AU - Sternkopf, M.

AU - Alampour-Rajabi, S.

AU - van Zandvoort, M.A.M.J.

AU - Kiessling, F.

AU - Wu, Z.J.

PY - 2020/11/26

Y1 - 2020/11/26

N2 - In the original article, there was an error. A statement on author contribution was incorrect. A correction has been made to the Author Contributions:.

AB - In the original article, there was an error. A statement on author contribution was incorrect. A correction has been made to the Author Contributions:.

KW - cancer therapy

KW - nanocarrier

KW - rfvt

KW - riboflavin

KW - targeting molecules

KW - theranostic

KW - RFVT

U2 - 10.3389/fphar.2020.617329

DO - 10.3389/fphar.2020.617329

M3 - Erratum / corrigendum

C2 - 33324229

SN - 1663-9812

VL - 11

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 617329

ER -

Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

Abstract

Keywords

Access to Document

Fingerprint

Research output

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

Cite this